SCHEMBL4687597

SCHEMBL4687597

COC1(C(=O)N2CC[CH]C(NC(=O)c3ccc(N4CCCCC4=O)cc3)C2C(N)=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.43
RAB9A P51151 3/20 0.43
TSHR P16473 2/20 0.43
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
ALDH1A1 P00352 3/20 0.41
F10 P00742 7/20 0.40
POLB P06746 2/20 0.40
F2 P00734 1/20 0.40
LCK P06239 1/20 0.38
JAK3 P52333 1/20 0.38
ATM Q13315 1/20 0.38
MAPT P10636 2/20 0.37
RECQL P46063 1/20 0.37
GFER P55789 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5434250 0.86 NPC1 (0.49) NPC1RAB9ATSHRHPGDSMN1; SMN2
SCHEMBL4687839 0.82 F10 (0.46) F10
SCHEMBL4691171 0.80 NPC1 (0.46) NPC1RAB9ATSHRHPGDSMN1; SMN2
SCHEMBL4691272 0.79 NPC1 (0.48) NPC1RAB9ATSHRHPGDSMN1; SMN2
SCHEMBL5429983 0.72 NPC1 (0.50) NPC1RAB9ATSHRHPGDSMN1; SMN2
SCHEMBL4690862 0.69 F10 (0.44) F10F2
SCHEMBL5438310 0.68 NPC1 (0.52) NPC1RAB9ATSHRHPGDSMN1; SMN2
SCHEMBL5428982 0.68 NPC1 (0.52) NPC1RAB9ATSHRHPGDSMN1; SMN2
SCHEMBL5443489 0.67 HPGD (0.54) NPC1RAB9ATSHRHPGDSMN1; SMN2
SCHEMBL4693183 0.67 NPC1 (0.51) NPC1RAB9ATSHRHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603572-A4 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2008-06-25 EP disclosed
EP-1603572-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2005-12-14 EP disclosed
WO-2004082687-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed